36C24226Q0938.docx

Special Notice Special Notice

GENERAL INFORMATION

Network Contracting Office 2 James J. Peters VA Medical Center 130 West Kingsbridge Road Bronx NY 10468-3904

POINT OF CONTACT*

Morgan Weeks Morgan.Weeks1@va.gov

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

This is a notice of intent to award a sole source contract and is not a request for quotes.

The Department of Veterans Affairs on behalf of the Buffalo VA Medical Center intends to award a Firm Fixed Price (FFP), sole source action to Large Businesses (LB).

The Pathology and Laboratory Medicine Department requires reagents and supplies outlined in this procurement to continue to perform patient testing on the Thermo Fisher Genexus instrument, and Genexus Purification System. Both instruments are owned and operated by the Buffalo VAMC Pathology and Laboratory Medicine department. The Genexus instrument utilizes the Oncomine Precision Assay which enables simultaneous detection of biomarkers across 50 genes, including key targets within EGFR, BRAF, KRAS, ALK, ROS1, NTRK, RET, HER2, and others, from solid tissue samples. Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The OPA NGS panel has significant clinical utility in cancer treatment by providing comprehensive genomic profiling of a tumor sample, allowing healthcare providers to identify actionable genetic alterations and select the most appropriate targeted therapies for a patient based on their specific tumor mutations, leading to more effective treatment plans.

This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a).

The Department of Veterans Affairs, Buffalo, NY location intends to issue a sole source award contract to Thermo Fisher Scientific, all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored.

NAICS Code: 325413 – In-Vitro Diagnostic Substance Manufacturing Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer’s intended distribution channels.

This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on August 27, 2025. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Gove

Special Notice